HALDOL DECANOAS

This brand name is authorized in Germany, Ecuador, France, Hong Kong, Mexico, Tunisia

Active ingredients

The drug HALDOL DECANOAS contains one active pharmaceutical ingredient (API):

1 Haloperidol decanoate UNII AC20PJ4101 - HALOPERIDOL DECANOATE

Haloperidol is an antipsychotic belonging to the butyrophenones group. It is a potent central dopamine type 2 receptor antagonist, and at recommended doses, has low alpha-1 antiadrenergic activity and no antihistaminergic or anticholinergic activity. Read about Haloperidol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05AD01	Haloperidol	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AD Butyrophenone derivatives
Discover more medicines within N05AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00550338, 00550344, 03996106, 03996112, 04658570, 04959840, 04959857, 06631233, 06631256, 06951854, 06951860, 07149308, 07149314, 07233434, 07233440, 07286608, 07286614, 08772162, 08913007, 08913065, 10072029, 15194300, 15378980, 15895652, 16769257
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 27.218-08-06
Country: FR	Base de données publique des médicaments	Identifier(s): 61505095
Country: HK	Department of Health Drug Office	Identifier(s): 18132, 21615
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 335M81
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5740056A, 5740056B